Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,355.00
+105.00 (3.23%)
At close: Apr 24, 2026

Biotoxtech Revenue

In the year 2025, Biotoxtech had annual revenue of 47.02B KRW with 13.73% growth. Biotoxtech had revenue of 14.25B in the quarter ending December 31, 2025, with 24.75% growth.

Revenue
47.02B
Revenue Growth
+13.73%
P/S Ratio
1.12
Revenue / Employee
250.09M
Employees
188
Market Cap
52.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.02B5.68B13.73%
Dec 31, 202441.34B8.71B26.69%
Dec 31, 202332.63B-4.66B-12.50%
Dec 31, 202237.29B4.57B13.98%
Dec 31, 202132.72B6.29B23.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Omnisystem99.07B
Carelabs Co.,Ltd81.69B
Bankware Global63.45B
WOOJUNG BIO37.59B
The Cube &24.91B
Moadata23.17B
RN2 Technologies18.65B
GFC Life Science17.71B
Revenue Rankings